Lipid and polymeric nanoparticles: successful strategies for nose-to-Brain drug delivery in the treatment of depression and anxiety disorders

M Alberto, AC Paiva-Santos, F Veiga, PC Pires - Pharmaceutics, 2022 - mdpi.com
Intranasal administration has gained an increasing interest for brain drug delivery since it
allows direct transport through neuronal pathways, which can be quite advantageous for …

[HTML][HTML] Intranasal polymeric and lipid-based nanocarriers for CNS drug delivery

R Maher, A Moreno-Borrallo, D Jindal, BT Mai… - Pharmaceutics, 2023 - mdpi.com
Nanomedicine is currently focused on the design and development of nanocarriers that
enhance drug delivery to the brain to address unmet clinical needs for treating …

JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions

A Sarapultsev, E Gusev, M Komelkova, I Utepova… - Molecular …, 2023 - Springer
The Janus kinase-signal transducer and transcription activator pathway (JAK-STAT) serves
as a cornerstone in cellular signaling, regulating physiological and pathological processes …

Current and future directions of drug delivery for the treatment of mental illnesses

PR Brewster, SMI Bari, GM Walker, TA Werfel - Advanced Drug Delivery …, 2023 - Elsevier
Mental illnesses including anxiety disorders, autism spectrum disorder, post-traumatic stress
disorder, schizophrenia, depression, and others exact an immense toll on the healthcare …

Fear extinction induced by activation of PKA ameliorates anxiety-like behavior in PTSD mice

F Gao, J Wang, S Yang, M Ji, G Zhu - Neuropharmacology, 2023 - Elsevier
Prolonged exposure (PE) therapy aiming to promote fear extinction is a useful treatment for
post-traumatic stress disorder (PTSD). However, the mechanisms underlying fear extinction …

Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders

EJ Patharapankal, AL Ajiboye, C Mattern, V Trivedi - Pharmaceutics, 2023 - mdpi.com
In recent years, there have been a growing number of small and large molecules that could
be used to treat diseases of the central nervous system (CNS). Nose-to-brain delivery can …

The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review

M Mennetrier, PM Llorca, L Samalin - Pharmaceutics, 2023 - mdpi.com
Ketamine and its enantiomers represent an innovative glutamatergic agent as a treatment
for individuals with treatment-resistant depression (TRD) and major depressive disorder …

Intranasal esketamine combined with oral midazolam provides adequate sedation for outpatient pediatric dental procedures: a prospective cohort study

J Wang, J Zeng, N Zhao, S Chen, Z Chen… - … Journal of Surgery, 2023 - journals.lww.com
Background: Severe dental phobia or failure to cooperate with treatment are very common in
outpatient pediatric dentistry. Personalized and appropriate noninvasive anesthesia …

[HTML][HTML] Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma

LM Arms, RJ Duchatel, ER Jackson… - Journal of Controlled …, 2024 - Elsevier
Diffuse midline glioma (DMG), including tumors diagnosed in the brainstem (diffuse intrinsic
pontine glioma-DIPG), is the primary cause of brain tumor-related death in pediatric patients …

Nose-to-Brain Drug Delivery and Physico-Chemical Properties of Nanosystems: Analysis and Correlation Studies of Data from Scientific Literature

A Bonaccorso, A Ortis, T Musumeci… - International Journal …, 2024 - Taylor & Francis
Background In the last few decades, nose-to-brain delivery has been investigated as an
alternative route to deliver molecules to the Central Nervous System (CNS), bypassing the …